Music Producer
B.S., M.A. Political Science (Arizona State University)
Disabled with Multiple Sclerosis
From: Chicago; Lived in Los Angeles
SAG-AFTRA, ASCAP
It is difficult—almost impossible—to find a therapy capable of reversing as many characteristics of aging as cellular reprogramming.
Right before our eyes, the tool that can turn eternal youth into a tangible reality already exists.
That's all.
@rand_longevity Observation:
Biology produced intelligence.
Intelligence produced software.
Software is studying biology.
The circle appears to be closing.
A groundbreaking medical study revealed that aging may be transmitted through the bloodstream via a protein called HMGB1. When researchers blocked this protein in animal tests, they observed remarkable results: damaged tissues began to repair themselves, and some age-related decline was reversed.
This discovery suggests that aging is not simply an inevitable process of cell breakdown but may be influenced by specific molecular signals. If these signals can be controlled, aging could be slowed — or even partially reversed.
Such treatments could revolutionize medicine, offering new ways to fight diseases like Alzheimer’s, arthritis, and organ failure, all of which are tied to aging. However, researchers caution that human trials are still far away.
The study fuels hope that one day aging itself might be treated as a medical condition, reshaping human health and longevity.
Supermicro’s AI Factory solutions, in partnership with NVIDIA, provide telecom operators with a complete, turnkey platform to build their sovereign AI infrastructure.
The world’s first anti-aging gene therapy has been injected into a human for the first time. In June 2026, Boston-based Life Biosciences announced that the first patient received a dose of their experimental therapy ER-100 in a Phase 1 clinical trial.
The treatment uses partial epigenetic reprogramming by delivering three Yamanaka factors (OCT4, SOX2, and KLF4) to restore aged or damaged cells to a more youthful state. It is currently being tested as an injection into the eye for age-related optic neuropathies, including open-angle glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION).
This milestone marks the first time partial cellular reprogramming technology has been administered to a human. While the current trial focuses on safety and vision outcomes in the eye, it represents a major step toward broader anti-aging applications.
[Life Biosciences. (2026). Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER-100 for Optic Neuropathies. Company Press Release, June 9, 2026]
This is a really exciting aging discovery
Scientists found that aging cells may lose energy partly because levels of phosphatidylcholine, a key membrane lipid, decline with age.
This makes mitochondria less flexible, more fragmented, and less efficient, basically weakening the cell’s internal power grid.
Remarkably, when researchers boosted phosphatidylcholine or its precursor choline in aging lab organisms, mitochondrial structure and energy function improved, suggesting that some parts of cellular aging may be reversible.
Computing is undergoing its biggest shift in 60 years.
Our CEO Jensen Huang explains why the world is moving from retrieval to generation—expanding what humanity can build, discover, and solve.
This shift represents a multi trillion dollar opportunity across the 5 layer AI cake ecosystem.
@Sequoia
After 25 years of brave & brilliant work by hundreds of scientists in my lab to understand then safely reverse aging for the first time, it was moving to witness the first human dose being delivered 🥹 https://t.co/veQsyUEORz
The man who invented the first reading machine for the blind, has a new prediction that will either change how you live or sound completely insane.
"By around 2032, people who are diligent with their health are going to reach what we call longevity escape velocity."
"This is when scientific breakthroughs will add more time to our manual life expectancy than is going by. So we'll be going backwards in time as far as our health is concerned."
"As we merge with AI in this way, we will become a hybrid species. We'll still be human, but we'll be enhanced by AI."
"I want to live indefinitely because I want to see my loved ones and I want to continue working on my creative projects. I don't see a time when I would not feel that way."
PS. If you found value in this post make sure to like and repost the first tweet + follow @uncover_ai to stay updated with the latest AI news.
See you in the next one:
The @Cubs over their last 20 games:
17 total wins
10 comeback wins
9 wins after allowing the first run
6 one-run wins
4 walkoff wins
4 wins after trailing in 8th or later
3 extra-inning wins
No other MLB team in the modern era has done all of that over any 20-game span.